2024 One Health Microbiome Symposium

Date and Time
Location
Huck Life Sciences Building
Research Themes

The One Health Microbiome Symposium is the second biennial symposium hosted by the One Health Microbiome Center, one of the largest and most active interdisciplinary microbiome centers. Join us May 30-31st, 2024 at the University Park Campus of The Pennsylvania State University.

The symposium will feature internationally-renowned keynote speakers, faculty and trainee research talks, poster sessions, and networking events. The goal of the One Health Microbiome Symposium is to showcase how diverse ecosystems are dependent upon their microbial communities and how microbes flow through these ecosystems to shape the outcomes of health and disease. The biennial event creates an ongoing, supportive, diverse, and intimate environment for microbiome researchers at all career stages to connect.

Distinguished keynote speakers include: 

  • Paul Schulze-Lefert, renowned for his expertise in plant-microbial interactions and the innate immune system of plants; Schulze-Lefert is an elected member of the National Academy of Sciences, USA, the German National Academy of Sciences, Leopoldina, the American Academy of Microbiology, USA, and European Molecular Biology Organization. 
  • Edith Hammer is a trailblazer in microbial ecology and studies plant-fungi symbioses and their abilities to alter the surrounding soil composition. Hammer leads the branch for climate and C-cycle science of the strategic research environment BECC, the Section Soil Biology at the European Geosciences Union, and 2023’s Microsoil Network.
  • Maria Gloria Dominguez-Bello is a leading figure in human microbiome research at Rutgers University where her lab focuses on understanding the development of the human microbiome from birth and how early perturbations may alter its makeup. Dominguez-Bello is a fellow of the American Academy of Microbiology and of the Infectious Disease Society of America (IDSA), as well as a member of the editorial board and reviewer at several scientific journals.
  • Steffanie Strathdee, a pioneer in infectious disease epidemiology, is a global public health ambassador and the architect behind the first successful bacteriophage treatment of a multi-drug resistant infection in the U.S. Strarthdee is the Associate Dean of Global Health Sciences and Harold Simon Distinguished Professor of Medicine at the University of California San Diego. She co-directs the Center for Innovative Phage Applications and Therapeutics (IPATH).